KOD

NASD Kodiak Sciences, Inc.

Oct 23, 2026 · 7:24 AM ET LAST TRADE Market Closed

$85.11 ↓ -0.67 (-0.78%) Trading Down from the previous close of $85.78

YTD change: +204.40%
vs 20-day SMA: -4.16%
vs 200-day SMA: +112.25%

Price ranges

Previous day

$84.86 $89.52

open $87.14 close $85.78

-$1.36 (-1.56%)

Today

$0.00 $0.00

$85.11

Past week

$84.86 $96.12

from $88.12 now $85.11

-$3.01 (-3.42%)

Past month

$31.00 $104.00

from $33.22 now $85.11

+$51.89 (+156.20%)

This year

$20.88 $104.00

from $27.96 now $85.11

+$57.15 (+204.40%)

Price & Performance

+40.57 (+89.74%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 50.3% away from all-time highs of $171.21
KOD is up 204% since the beginning of the year
KOD is up 397% over the past 12 months
KOD is up 156% over the past 1 month
46% of all KOD investors are betting against KOD

KOD reads neutral: price sits above one of the two key moving averages, the 12-month move is +401.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-1.05

Earnings momentum +1.2% Quarterly EPS growth

Quarterly change +1.2%

Valuation

P/E ratio N/A

Enterprise value $5.4B

Beta 1.18

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$125.9M

Debt$152.8K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $5.3B

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Competitor comparison

Ticker	Company	Price	Change
AMGN	Amgen Inc.	$447.28	+2.04%
MRNA	Moderna, Inc.	$202.63	-17.57%
RVMD	Revolution Medicines, Inc.	$187.69	-3.39%
ROIV	Roivant Sciences Ltd.	$37.45	+1.77%
BNTX	BioNTech SE Sponsored ADR	$89.67	-1.77%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.